Formulary Search
Search Results : Lipid modification (Ezetimibe - Lipid modification)
Records returned : 20 (on 05 Dec 2025 at 18:29:32).
Return to search results for ' Lipid modification '.
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Only as add-on therapy for patients already on ezetimibe. Use the combination product (bempedoic acid with ezetimibe) in new patients.
Bempedoic acid should not be considered for patients taking a statin as per NICE TA694 recommendations.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Bempedoic acid should not be considered for patients taking a statin as per NICE TA694 recommendations.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
With statin therapy in patients with raised triglycerides
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Prescribing in secondary care is commissioned by NHSE
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Rosuvastatin capsules are considerably more expensive and should not be prescribed.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
- Tablets
Restrictions / Comments:
Important
Primary care prescribing on recommendation from specialist team for Familial hypercholesterolaemia and hypertriglyceridaemia.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Primary care prescribing on recommendation from specialist team for Familial hypercholesterolaemia and hypertriglyceridaemia.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Hypercholesterolaemia. Primary care prescribing on specialist team recommendation.
Links :
Indication :
Status :
Formulations :
- Sachets (powder)
Restrictions / Comments:
Important
Hypercholesterolaemia. Primary care prescribing on specialist team recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Tablets
Restrictions / Comments:
Important
Primary care prescribing on recommendation from specialist team for Familial hypercholesterolaemia and hypertriglyceridaemia.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Restricted to lipidologists only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Restricted to lipidologists only for heterozygous familial and non-familial hypercholesterolaemia.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Tablets
Restrictions / Comments:
Important
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
This drug has not yet been assessed for formulary status. Contact your pharmacy team for advice on making an application to APC.
Formulary Status :
Links :